Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Regulated mRNA Transport

Regulated mRNA Transport

In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Massively parallel reporter assay for mapping gene-specific regulatory regions at single-nucleotide resolution.

eLife·2026

Same author

AAV NRF2 gene therapy preserves retinal structure and function in rodent models of oxidative damage.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Humanized Extracellular Vesicles for Efficient RNA Delivery.

bioRxiv : the preprint server for biology·2025

Same author

Massively parallel reporter assay for mapping gene-specific regulatory regions at single nucleotide resolution.

bioRxiv : the preprint server for biology·2025

Same author

RPE-specific MCT2 expression promotes cone survival in models of retinitis pigmentosa.

Proceedings of the National Academy of Sciences of the United States of America·2025

Same journal

Chemotactic self-organization captures the dynamics of mammalian hair follicle patterning.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Tomographic imaging of superconducting order using particle-hole interference.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Inhibitory potential of autologous neutralizing antibodies sets quantitative limits on the rebound-competent HIV-1 reservoir.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Analytical modeling for suction cup designs for skin-interfaced wearable devices.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same journal

Improving cell-free metabolism through direct integration of artificial respiratory chains.

Proceedings of the National Academy of Sciences of the United States of America·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 9, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Humanized extracellular vesicles for efficient RNA delivery.

Xiang Ma^1,2, Sophia R Zhao^1,2, Constance L Cepko^1,2

¹Department of Genetics, Harvard Medical School, Boston, MA 02115.

Proceedings of the National Academy of Sciences of the United States of America

|April 7, 2026

Summary

This summary is machine-generated.

Researchers developed a new assay to optimize engineered extracellular vesicles (EVs) for RNA delivery. This human-derived EV system shows efficient RNA delivery and reduced immunogenicity, offering a promising alternative to viral vectors.

Keywords:

EABR Epsin N-terminal homology (ENTH)citramalyl-CoA lyase beta-like protein (CLYBL)enveloped protein nanocages (EPNs)functional titers

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Experiment Videos

Last Updated: Apr 9, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Area of Science:

Biotechnology
Molecular Biology
Nanomedicine

Background:

Engineered extracellular vesicles (EVs) are promising nonviral vectors for RNA delivery.
Enveloped protein nanocages (EPNs) enhance cargo loading but require better optimization assays.
Current methods lack single-unit activity assessment for EPNs.

Purpose of the Study:

To develop a biological titration assay for single, active engineered EVs.
To optimize engineered EVs using a modular, human-derived protein platform.
To evaluate the RNA delivery efficiency and immunogenicity of the optimized EVs.

Main Methods:

Developed a biological titration assay for engineered EVs, adapted from infectious viral particle methods.
Engineered EVs using a modular platform with human-derived protein components (epsin 1, CLYBL, CEP55).
Incorporated a nonhuman peptide for RNA packaging.

Main Results:

Achieved efficient RNA delivery with functional titers comparable to lentiviral vectors.
The optimized human-derived EVs demonstrated reduced immunogenicity compared to EPNs and VLPs.
The new assay enables direct comparison and optimization of engineered EV variants.

Conclusions:

The developed assay facilitates the optimization of engineered EVs for RNA delivery.
The human-derived EV system offers efficient RNA delivery with potentially lower immunogenicity.
This platform represents a significant advancement in nonviral gene therapy and vaccine delivery vectors.